Erratum: Comparative genomic analysis of primary and synchronous metastatic colorectal cancers (PLoS ONE 9(3) (e90459) DOI: 10.1371/journal.pone.0090459);Comparative genomic analysis of primary and synchronous metastatic colorectal cancers

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Lee, Sun Young ^a   Haq, Farhan ^a   Kim, Deokhoon ^b   Jun, Cui ^a   Jo, Hui Ng ^a   Ahn, Sung Min ^b   Lee, Won Suk ^a  

^a Gachon University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; DNA; K RAS PROTEIN; MISMATCH REPAIR PROTEIN; PROTEIN P53; TP53 PROTEIN, HUMAN; VASCULOTROPIN RECEPTOR;

ADULT; AGED; APC GENE; ARID1A GENE; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COLORECTAL LIVER METASTASIS; COPY NUMBER VARIATION; DNA MISMATCH REPAIR GENE; EXOME; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC HETEROGENEITY; GENETIC SIMILARITY; GENOMICS; HUMAN; HUMAN TISSUE; KRAS GENE; LIVER TUMOR; MALE; METASTATIC COLORECTAL CANCER; NUCLEOTIDE SEQUENCE; PIK3CA GENE; PRIMARY TUMOR; SOMATIC HYPERMUTATION; SOMATIC MUTATION; TP53 GENE; CLUSTER ANALYSIS; COLORECTAL TUMOR; COMPARATIVE STUDY; DNA REPAIR; GENETICS; HETEROZYGOSITY LOSS; METASTASIS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; POINT MUTATION; SECONDARY; SIGNAL TRANSDUCTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; DNA COPY NUMBER VARIATIONS; DNA MUTATIONAL ANALYSIS; DNA REPAIR; EXOME; FEMALE; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; POINT MUTATION; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84897132007     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117753     Document Type: Erratum

References (50)

1. Halberg RB, Dove WF (2007) Polyclonal tumors in the mammalian intestine: are interactions among multiple initiated clones necessary for tumor initiation, growth, and progression? Cell Cycle 6: 44-51. (Pubitemid 46173879)
2. Navin NE, Hicks J (2010) Tracing the tumor lineage. Molecular Oncology 4: 267-283. doi:10.1016/j.molonc.2010.04.010.
3. Norton L (2008) Cancer stem cells, self-seeding, and decremented exponential growth: theoretical and clinical implications. Breast Dis 29: 27-36.
4. Parsons BL (2008) Many different tumor types have polyclonal tumor origin: Evidence and implications. Mutation Research/Reviews in Mutation Research 659: 232-247. doi:10.1016/j.mrrev.2008.05.004.
5. Visvader JE (2011) Cells of origin in cancer. Nature 469: 314-322. doi:10.1038/nature09781.
6. Talmadge JE, Fidler IJ (2010) AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective. Cancer Res 70: 5649-5669. doi:10.1158/0008-5472.CAN-10-1040.
7. McCune CS, Schapira DV, Henshaw EC (1981) Specific immunotherapy of advanced renal carcinoma: evidence for the polyclonality of metastases. Cancer 47: 1984-1987. (Pubitemid 11153435)
8. Siegmund KD, Marjoram P, Tavaré S, Shibata D (2009) Many colorectal cancers are "flat" clonal expansions. Cell Cycle 8: 2187-2193.
9. Palena C, Fernando RI, Litzinger MT, Hamilton DH, Huang B, et al. (2011) Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells. Experimental Biology and Medicine 236: 537-545. doi:10.1258/ebm.2011.010367.
10. Cho E, Smith-Warner SA, Spiegelman D, Beeson WL, Brandt PAvd, et al. (2004) Dairy Foods, Calcium, and Colorectal Cancer: A Pooled Analysis of 10 Cohort Studies. JNCI J Natl Cancer Inst 96: 1015-1022. doi:10.1093/jnci/ djh185.
11. Stürmer T, Glynn RJ, Lee I-M, Christen WG, Hennekens CH (2000) Lifetime Cigarette Smoking and Colorectal Cancer Incidence in the Physicians' Health Study I. JNCI J Natl Cancer Inst 92: 1178-1181. doi:10.1093/jnci/92.14. 1178.
12. Van Cutsem E, Oliveira J, On behalf of the ESMO Guidelines Working Group (2009) Advanced colorectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology 20: iv61-iv63. doi:10.1093/annonc/ mdp130.
13. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, et al. (2006) Epidemiology and Management of Liver Metastases From Colorectal Cancer. Ann Surg 244: 254-259. doi:10.1097/01.sla.0000217629.94941.cf. (Pubitemid 44305540)
14. Dix BR, Robbins PD, Spagnolo DV, Padovan GL, House AK, et al. (1995) Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markers. Diagn Mol Pathol 4: 261-265.
15. Fearon ER, Hamilton SR, Vogelstein B (1987) Clonal analysis of human colorectal tumors. Science 238: 193-197. (Pubitemid 17139720)
16. Beutler E, Collins Z, Irwin LE (1967) Value of Genetic Variants of Glucose-6-Phosphate Dehydrogenase in Tracing the Origin of Malignant Tumors. New England Journal of Medicine 276: 389-391. doi:10.1056/NEJM196702162760706.
17. Hsu SH, Luk GD, Krush AJ, Hamilton SR, Hoover HH Jr (1983) Multiclonal origin of polyps in Gardner syndrome. Science 221: 951-953. (Pubitemid 13041999)
18. Turajlic S, Furney SJ, Lambros MB, Mitsopoulos C, Kozarewa I, et al. (2012) Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res 22: 196-207. doi:10.1101/gr.125591.111.
19. Campbell PJ, Yachida S, Mudie LJ, Stephens PJ, Pleasance ED, et al. (2010) The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467: 1109-1113. doi:10.1038/nature09460.
20. Yachida S, Jones S, Bozic I, Antal T, Leary R, et al. (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114-1117. doi:10.1038/nature09515.
21. Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, et al. (2009) Copy Number Analysis Indicates Monoclonal Origin of Lethal Metastatic Prostate Cancer. Nat Med 15: 559-565. doi:10.1038/nm.1944.
22. Klein CA (2009) Parallel progression of primary tumours and metastases. Nat Rev Cancer 9: 302-312. doi:10.1038/nrc2627.
23. Torres L, Ribeiro FR, Pandis N, Andersen JA, Heim S, et al. (2007) Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases. Breast Cancer Res Treat 102: 143-155. doi:10.1007/s10549-006-9317-6. (Pubitemid 46452166)
24. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158. doi:10.1038/nature05610. (Pubitemid 46398669)
25. Knijn N, Mekenkamp LJM, Klomp M, Vink-Börger ME, Tol J, et al. (2011) KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients. Br J Cancer 104: 1020-1026. doi:10.1038/bjc.2011.26.
26. Baldus SE, Schaefer K-L, Engers R, Hartleb D, Stoecklein NH, et al. (2010) Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases. Clin Cancer Res 16: 790-799. doi:10.1158/1078-0432.CCR-09-2446.
27. Kim M-J, Lee HS, Kim JH, Kim YJ, Kwon JH, et al. (2012) Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer. BMC Cancer 12: 347. doi:10.1186/1471-2407-12-347.
28. Albanese I, Scibetta AG, Migliavacca M, Russo A, Bazan V, et al. (2004) Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations. Biochemical and Biophysical Research Communications 325: 784-791. doi:10.1016/j.bbrc.2004.10. 111. (Pubitemid 39487940)
29. Boland CR, Goel A (2010) Microsatellite instability in colorectal cancer. Gastroenterology 138: 2073-2087.e3. doi:10.1053/j.gastro.2009.12.064.
30. Dong G, Guo X, Fu X, Wan S, Zhou F, et al. (2012) Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer. Cancer Sci 103: 561-568. doi:10.1111/j.1349-7006.2011.02194. x.
31. Wang L, Tsutsumi S, Kawaguchi T, Nagasaki K, Tatsuno K, et al. (2012) Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency. Genome Res 22: 208-219. doi:10.1101/gr.123109.111.
32. Nakao K, Mehta KR, Fridlyand J, Moore DH, Jain AN, et al. (2004) Highresolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 25: 1345-1357. doi:10.1093/carcin/bgh134. (Pubitemid 39162701)
33. Trautmann K, Terdiman JP, French AJ, Roydasgupta R, Sein N, et al. (2006) Chromosomal Instability in Microsatellite-Unstable and Stable Colon Cancer. Clin Cancer Res 12: 6379-6385. doi:10.1158/1078-0432.CCR-06-1248. (Pubitemid 44799708)
34. Jasmine F, Rahaman R, Dodsworth C, Roy S, Paul R, et al. (2012) A Genome-Wide Study of Cytogenetic Changes in Colorectal Cancer Using SNP Microarrays: Opportunities for Future Personalized Treatment. PLoS ONE 7: e31968. doi:10.1371/journal.pone.0031968.
35. Jones AM, Douglas EJ, Halford SE, Fiegler H, Gorman PA, et al. (2005) Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma. Oncogene 24: 118-129. doi:10.1038/sj.onc.1208194. (Pubitemid 40143871)
36. Goel A, Arnold CN, Niedzwiecki D, Chang DK, Ricciardiello L, et al. (2003) Characterization of Sporadic Colon Cancer by Patterns of Genomic Instability. Cancer Res 63: 1608-1614. (Pubitemid 36373651)
37. Camps J, Armengol G, Rey J del, Lozano JJ, Vauhkonen H, et al. (2006) Genome-wide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis 27: 419-428. doi:10.1093/carcin/bgi244. (Pubitemid 43372871)
38. Li LS, Kim N-G, Kim SH, Park C, Kim H, et al. (2003) Chromosomal imbalances in the colorectal carcinomas with microsatellite instability. Am J Pathol 163: 1429-1436. doi:10.1016/S0002-9440(10)63500-6. (Pubitemid 37175090)
39. Spratlin JL, Cohen RB, Eadens M, Gore L, Camidge DR, et al. (2010) Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2. JCO 28: 780-787. doi:10.1200/JCO.2009.23.7537.
40. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-257. doi:10.1038/35025220.
41. Wang Y, Zheng Y, Zhang W, Yu H, Lou K, et al. (2007) Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol 50: 760-767. doi:10.1016/j.jacc.2007.04.074. (Pubitemid 47243798)
42. Zhang W, Sun K, Zhen Y, Wang D, Wang Y, et al. (2009) VEGF receptor-2 variants are associated with susceptibility to stroke and recurrence. Stroke 40: 2720-2726. doi:10.1161/STROKEAHA.109.554394.
43. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760. doi:10.1093/ bioinformatics/btp324.
44. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, et al. (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nature Genetics 43: 491-498. doi:10.1038/ng.806.
45. Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, et al. (2012) VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22: 568-576. doi:10.1101/gr.129684.111.
46. Saunders CT, Wong WSW, Swamy S, Becq J, Murray LJ, et al. (2012) Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28: 1811-1817. doi:10.1093/bioinformatics/bts271.
47. Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, et al. (2013) Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotech 31: 213-219. doi:10.1038/nbt.2514.
48. Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucl Acids Res 38: e164-e164. doi:10.1093/nar/gkq603.
49. Consortium T 1000 GP (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073. doi:10.1038/nature09534.
50. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, et al. (2010) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Research 39: D945-D950. doi:10.1093/nar/gkq929.